Novomedicon ApS: Financial statements 2024
CVR: 38818791
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Novomedicon ApS (CVR 38818791) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,538 and a net result of DKK -7,538 compared with DKK -7,262 the year before. Equity in the 2024 report amounted to DKK 12,723. The solvency ratio was 1.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -7,538
- Profit/Loss
- DKK -7,538
- Equity
- DKK 12,723
- Total Assets
- DKK 741,526
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -8K | -8K | 13K | 1 |
| 2023 | - | -7K | -7K | 20K | 1 |
| 2022 | - | -7K | -7K | 28K | - |
| 2021 | - | - | -522 | 35K | - |
| 2020 | - | 0 | -5K | -5K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Novomedicon ApS has published its annual report for 2023. Gross profit came to DKK -7,258, and the net result was DKK -7,262.
About Novomedicon ApS
Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.
